Researchers from World's No. 1 Reproductive Immunology Program Address Infertility at ASRI Annual Meeting

NORTH CHICAGO, Ill., July 1, 2026 /PRNewswire/ -- Researchers from Rosalind Franklin University's Reproductive Immunology program, which is ranked No. 1 in the world by ScholarGPS, presented groundbreaking data in reproductive immunology at the annual meeting of the American Society of Reproductive Immunology (ASRI), May 24–28, in Lexington, Kentucky. Presenters included the No. 7–ranked clinician-scientist in the field today, Joanne Kwak-Kim, MD, MPH, FCRI, ASRI, RFU's director of reproductive medicine and immunology, who chaired a session called "Breaking Barriers: Innovative Immunotherapies in Human Reproduction."

Infertility rates in the United States are increasing. Reproductive immunology plays an important role in identifying and treating immune-mediated causes of infertility, which has significant implications for advancing women's health. The U.S. total fertility rate — the average number of children a woman is expected to have during her lifetime — fell from about 3.6 in 1960 to 1.6 in recent years. This is well below the replacement rate of 2.1 required to maintain a stable population absent immigration. Annual births have declined as well, falling from a peak of more than 4.3 million in 2007 to closer to 3.6 million today.

"While these numbers reflect different factors, identifying factors and mechanisms associated with infertility puts us one step closer to finding ways to correct deficits and promote successful pregnancies," said Janice Urban, PhD, RFU's interim executive vice president of research. "The pioneering work conducted by our Reproductive Immunology and Clinical Immunology Laboratory researchers reflects RFU's position as a global leader in the field."

In addition to Dr. Kwak-Kim, RFU presenters included:

• Thanh Luu, DO, assistant director of reproductive medicine and immunology at RFU Health Clinics, participated in Dr. Kwak-Kim's session with a talk on "the endometrial environment and reproductive failures."
• Riyas Ali, MD, MRCOG, a reproductive immunology fellow, participated in a session called "Myeloid Cells in Genital Inflammation, Immune Protection and Reproduction" with a talk on "dose-dependent effects of sex steroid hormones on cytokine production by human peripheral blood mononuclear cells."
• Khaliun Dashdeleg, MPH, MD, a reproductive immunology fellow, gave a talk on "immunotherapy outcomes in diminished ovarian reserve versus normal ovarian reserve patients with recurrent pregnancy loss: a single-center retrospective study" during the session called "The Fallopian Tube Immune Microenvironment: Implications for Infertility, Ectopic Pregnancy and Ovarian Cancer."

RFU research was also presented in poster sessions:

• "Beyond Ovarian Reserve: Anti-Müllerian Hormone as a Direct Immune Signaling Regulator In Reproductive Failure" was presented by Umida Ganieva, MD, PhD; Mahmood Bilal, PhD, DABCC, FADLM, TS(ABB), MLS(ASCP); Moaz Saeed, BSc, MBBS; Sydney Olinger, MA; Aera Han, MD, PhD; Dr. Dashdeleg; Dr. Ali; Dr. Luu; Dr. Kwak-Kim; and Svetlana Dambaeva, PhD, D(ABMLI), HCLD(ABB).
• "Impaired Immune Plasticity in Reproductive Failure: Differential Effects of BMP-7 and SOD3 on CXCR3/CXCR4/CD54 Expression" was presented by Dr. Han, Dr. Ganieva, Dr. Dambaeva, and Dr. Kwak-Kim.
• "Relationship Between IGF/IGFBP System and Natural Killer Cell Cytotoxicity in Women with Recurrent Implantation Failure and Recurrent Pregnancy Loss" was presented by Dr. Ali; Amy Adamik; Dr. Dashdeleg; Dr. Han; Yonju Kim; Dr. Luu; Dr. Ganieva; Mahmood Bilal, PhD, DABCC, FADLM, TS(ABB), MLS(ASCP); Dr. Dambaeva; and Dr. Kwak-Kim.
• "Autoimmune Modulation of Immune-Endocrine-Metabolic Regulation of Ovarian Reserve: a Cohort Study of 803 Women" was presented by Dr. Han, Monira Alzahrani, Dr. Luu, Dr. Dambaeva and Dr. Kwak-Kim.

About Rosalind Franklin University

Rosalind Franklin University of Medicine and Science is committed to serving the global population through the interprofessional education of health and biomedical professionals and the discovery of knowledge dedicated to improving wellness. Founded in Chicago in 1912, RFU embodies the spirit of inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in the areas of neuroscience, brain related diseases, inherited disorders, diabetes, obesity, and gait and balance, the university includes Chicago Medical School, College of Health Professions, College of Pharmacy, College of Nursing, Dr. William M. Scholl College of Podiatric Medicine, and the School of Graduate and Postdoctoral Studies. Learn more at rosalindfranklin.edu.

Contact: Office of Marketing and 
Communications 
[email protected] 

SOURCE Rosalind Franklin University of Medicine and Science